Nita A. Farahany
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nita A. Farahany has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Henry T. Greely
Stanford University , 559 Nathan Abbott Way, Stanford, CA 94305
3 shared publications Henry T. Greely
Stanford Univ, Law, Stanford, CA 94305 USA
2 shared publications- Khara M. Ramos
National Institutes of Health, Bethesda, Maryland 20892
2 shared publications - Anil Kumar Seth
University of Sussex
1 shared publication Aryn Gittis
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, USA
1 shared publication- Beatrice Capestany
Duke Initiative for Science & Society , Durham, North Carolina , USA
1 shared publication
Latest Publications
- 17 September 2026
- Published by Cambridge University Press (CUP) in Behavioral and Brain Sciences
- Vol. 49, e356
Towards evidence-based governance of potentially conscious technologies
Seth’s biological naturalism claims consciousness requires living systems. We propose experiments operationalizing this debate through testable predictions about allostasis-predictive processing, autopoiesis-recurrent processing, and causal closure-global workspace relationships. Using a probabilistic framework, we show how experimental results could reduce metaphysical disagreement about computational functionalism, motivating empirical research that informs both consciousness theory and governance of potentially conscious technologies.
- 17 September 2026
- Published by Cambridge University Press (CUP) in Behavioral and Brain Sciences
- Vol. 49, e356
Towards evidence-based governance of potentially conscious technologies
Seth’s biological naturalism claims consciousness requires living systems. We propose experiments operationalizing this debate through testable predictions about allostasis-predictive processing, autopoiesis-recurrent processing, and causal closure-global workspace relationships. Using a probabilistic framework, we show how experimental results could reduce metaphysical disagreement about computational functionalism, motivating empirical research that informs both consciousness theory and governance of potentially conscious technologies.
- Open Access
- 7 July 2026
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 13 (2)
Xenocortical mice: what can we learn, and how should this research progress?
A new study by researchers at Stanford University describes the development of ‘xenocortical mice’: mice with a cortex comprised almost entirely of human-derived neurons. Their groundbreaking research has the potential to enable medical breakthroughs for a range of neurological and psychiatric disorders. The researchers offer detailed analysis of the neurophysiological and behavioral properties of these chimeric mice, comparing them with both wild-type control mice, and ‘apallial’ mice lacking most of their cortex. Here, we outline some key findings from the study and ask what these findings tell us about the capacity for consciousness in these mice, as well as their potential for human-like properties of cognition or conscious experience. Based on this discussion, we summarize the ethical and regulatory landscape relevant to chimeric animals and lay out an ethically-informed research roadmap to guide future research in this important area.
- 7 July 2026
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 13 (2)
Open AccessXenocortical mice: what can we learn, and how should this research progress?
A new study by researchers at Stanford University describes the development of ‘xenocortical mice’: mice with a cortex comprised almost entirely of human-derived neurons. Their groundbreaking research has the potential to enable medical breakthroughs for a range of neurological and psychiatric disorders. The researchers offer detailed analysis of the neurophysiological and behavioral properties of these chimeric mice, comparing them with both wild-type control mice, and ‘apallial’ mice lacking most of their cortex. Here, we outline some key findings from the study and ask what these findings tell us about the capacity for consciousness in these mice, as well as their potential for human-like properties of cognition or conscious experience. Based on this discussion, we summarize the ethical and regulatory landscape relevant to chimeric animals and lay out an ethically-informed research roadmap to guide future research in this important area.
- Open Access
- 18 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (12) , 2415-2431
Roadmap for direct and indirect translation of optogenetics into discoveries and therapies for humans
Optogenetics has transformed basic research on neural circuitry, led to diverse experimental insights into human brain function and dysfunction, and opened pathways for clinical translation based on new understanding of how specific cell types contribute to cognition and behavior. Many of these translational pathways do not rely on the direct application of optogenetics in humans, but rather develop and advance other treatment modalities by leveraging causal knowledge derived from optogenetic circuit neuroscience. However, a recent proof-of-principle study—showing that optogenetics applied directly to the human central nervous system can treat blindness—underscores not only the curative potential but also the need for careful ethical consideration in the extension of direct optogenetic intervention to other disorders. Here, we review relevant considerations—including the selection of clinical indications, identification of molecular and optical strategies for specificity, and navigation of safety and regulatory issues—that together inform the development of optogenetic translation targeting cells and circuits that have been causally implicated through optogenetic discoveries.
- 18 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (12) , 2415-2431
Open AccessRoadmap for direct and indirect translation of optogenetics into discoveries and therapies for humans
Optogenetics has transformed basic research on neural circuitry, led to diverse experimental insights into human brain function and dysfunction, and opened pathways for clinical translation based on new understanding of how specific cell types contribute to cognition and behavior. Many of these translational pathways do not rely on the direct application of optogenetics in humans, but rather develop and advance other treatment modalities by leveraging causal knowledge derived from optogenetic circuit neuroscience. However, a recent proof-of-principle study—showing that optogenetics applied directly to the human central nervous system can treat blindness—underscores not only the curative potential but also the need for careful ethical consideration in the extension of direct optogenetic intervention to other disorders. Here, we review relevant considerations—including the selection of clinical indications, identification of molecular and optical strategies for specificity, and navigation of safety and regulatory issues—that together inform the development of optogenetic translation targeting cells and circuits that have been causally implicated through optogenetic discoveries.
- Top Cited PapersOpen Access
Beyond neural data: Cognitive biometrics and mental privacy
- 2 January 2024
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 24 (1) , 1-2
By Statute or by Common Law? The Legal Determination of Death
- 2 January 2024
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 24 (1) , 1-2
By Statute or by Common Law? The Legal Determination of Death
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 11 (1) , lsad032
U.S. public perceptions of the sensitivity of brain data
As we approach an era of potentially widespread consumer neurotechnology, scholars and organizations worldwide have started to raise concerns about the data privacy issues these devices will present. Notably absent in these discussions is empirical evidence about how the public perceives that same information. This article presents the results of a nationwide survey on public perceptions of brain data, to inform discussions of law and policy regarding brain data governance. The survey reveals that the public may perceive certain brain data as less sensitive than other ‘private’ information, like social security numbers, but more sensitive than some ‘public’ information, like media preferences. The findings also reveal that not all inferences about mental experiences may be perceived as equally sensitive, and perhaps not all data should be treated alike in ethical and policy discussions. An enhanced understanding of public perceptions of brain data could advance the development of ethical and legal norms concerning consumer neurotechnology.
- 1 January 2024
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 11 (1) , lsad032
Open AccessU.S. public perceptions of the sensitivity of brain data
As we approach an era of potentially widespread consumer neurotechnology, scholars and organizations worldwide have started to raise concerns about the data privacy issues these devices will present. Notably absent in these discussions is empirical evidence about how the public perceives that same information. This article presents the results of a nationwide survey on public perceptions of brain data, to inform discussions of law and policy regarding brain data governance. The survey reveals that the public may perceive certain brain data as less sensitive than other ‘private’ information, like social security numbers, but more sensitive than some ‘public’ information, like media preferences. The findings also reveal that not all inferences about mental experiences may be perceived as equally sensitive, and perhaps not all data should be treated alike in ethical and policy discussions. An enhanced understanding of public perceptions of brain data could advance the development of ethical and legal norms concerning consumer neurotechnology.
- 1 January 2022
- Published by Springer Nature
- p. 275-286
U.S. State Laws on the Determination of Death by Neurologic Criteria
- 1 January 2022
- Published by Springer Nature
- p. 275-286
U.S. State Laws on the Determination of Death by Neurologic Criteria
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6536) , 1320
The rise and fall of the “warrior gene” defense
Since a 1993 study suggested that a single gene might predispose an individual to violence (1), criminal defendants have argued that their genes made them commit the crime. Through genome-wide association studies, we now understand that thousands of gene variants each contribute a very small amount to behavioral variation between individuals, and the idea that a single gene could cause violent behavior has been rejected. In February, the so-called “warrior gene” theory as a criminal defense was dealt a blow by the New Mexico Supreme Court in the case of State v. Yepez (2), but the ruling did not go far enough. By failing to address the current scientific consensus, the court missed an opportunity to create the much-needed persuasive authority for other courts on this issue. We must improve communication between scientists and the legal system to ensure that courts can access and understand the most current science.
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6536) , 1320
The rise and fall of the “warrior gene” defense
Since a 1993 study suggested that a single gene might predispose an individual to violence (1), criminal defendants have argued that their genes made them commit the crime. Through genome-wide association studies, we now understand that thousands of gene variants each contribute a very small amount to behavioral variation between individuals, and the idea that a single gene could cause violent behavior has been rejected. In February, the so-called “warrior gene” theory as a criminal defense was dealt a blow by the New Mexico Supreme Court in the case of State v. Yepez (2), but the ruling did not go far enough. By failing to address the current scientific consensus, the court missed an opportunity to create the much-needed persuasive authority for other courts on this issue. We must improve communication between scientists and the legal system to ensure that courts can access and understand the most current science.